| 1320 |
Centers for Disease Control and Prevention |
Html |
en |
NCIRD | Overview | Immunizations and Respiratory Diseases |
National Center for Immunization and Respiratory Diseases (NCIRD). |
| MPEG | 0.625771 |
| death | 0.55111 |
| disability | 0.551483 |
| control | 0.550489 |
| different file formats | 0.967935 |
| branches | 0.603481 |
| NCIRD | 0.547036 |
| divisions | 0.607007 |
|
| Prevention | 0.551981 |
| PDF | 0.544221 |
| PPT | 0.677519 |
| immunization | 0.669086 |
| DOC | 0.617914 |
| Mission | 0.55223 |
| respiratory | 0.641602 |
|
CLICK HERE |
| 5468 |
Centers for Disease Control and Prevention |
Html |
en |
Nickel carbonyl - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 6050 |
Centers for Disease Control and Prevention |
Html |
en |
Nitroglycerine - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 7298 |
Centers for Disease Control and Prevention |
Html |
en |
Preventing Chronic Disease: Volume 9, 2012: 12_0005 |
CDC - Wide Page example description goes here |
| tumor cell growth | 0.453348 |
| follow-up period | 0.52187 |
| AMA PRA | 0.46781 |
| statin efficacy | 0.559366 |
| efficacious statins | 0.482791 |
| statin packs | 0.585933 |
| multivariable model | 0.45912 |
| initial statin medications | 0.543407 |
| statin medication | 0.597134 |
| statins efficacy | 0.51952 |
| Tel Aviv | 0.582069 |
| study follow-up period | 0.453783 |
| total follow-up time | 0.559561 |
| lower risk | 0.462594 |
| statin | 0.94679 |
| index date | 0.629947 |
| statin type | 0.519689 |
| incident cancer cases | 0.484053 |
| hydrophilic statins | 0.483438 |
| socioeconomic level | 0.45194 |
| statin dispensation | 0.612263 |
| nonpersistent statin users | 0.727091 |
| study | 0.563004 |
| overall cancer risk | 0.507605 |
|
| negative association | 0.495452 |
| non-Hodgkin lymphoma | 0.513148 |
| high-efficacy statins | 0.492567 |
| highest PDC quintile | 0.464437 |
| lower cancer risk | 0.499566 |
| statin types | 0.503878 |
| widespread statin consumption | 0.625628 |
| strong negative association | 0.451168 |
| statins therapy | 0.555081 |
| health maintenance organization | 0.458399 |
| initial statin therapy | 0.564675 |
| statin medications | 0.589135 |
| Tel Aviv University | 0.55451 |
| lipophilic statin users | 0.548899 |
| statin persistence | 0.509346 |
| statin users | 0.895727 |
| statin therapy | 0.836176 |
| relevant financial relationships | 0.510841 |
| statins | 0.926564 |
| initial statins therapy | 0.538685 |
| highest cancer risk | 0.514911 |
| hematopoietic cancer risk | 0.459421 |
| Sackler Faculty | 0.449283 |
| cancer risk | 0.730804 |
|
CLICK HERE |
| 8841 |
Centers for Disease Control and Prevention |
Html |
en |
Tourette Syndrome: New Treatment Option | CDC Features |
null |
| CDC | 0.473702 |
| Texas A&M University | 0.508582 |
| Arch Gen Psychiatry | 0.498805 |
| effective treatment | 0.464296 |
| promising treatment | 0.470347 |
| different behavior | 0.467593 |
| tics | 0.916532 |
| sudden twitches | 0.470408 |
| new skills | 0.460324 |
| tourette syndrome | 0.794102 |
| things | 0.461143 |
| Behavior therapy | 0.459758 |
| Tourette disorder | 0.47194 |
| new behavior | 0.544388 |
| Obsessive Compulsive Disorder | 0.523138 |
| health professionals | 0.50727 |
| severe tics | 0.620718 |
| promising behavioral treatment | 0.533345 |
| additional diagnosed condition | 0.522891 |
| specific treatment | 0.461537 |
| Tourette Syndrome Association | 0.537401 |
| Comprehensive Behavioral Intervention | 0.5146 |
| large scale studies | 0.503427 |
| health problems | 0.463976 |
|
| specific needs | 0.460242 |
| person | 0.507042 |
| slow rhythmic breathing | 0.508003 |
| Attention Deficit/Hyperactivity Disorder | 0.52238 |
| stressful situations | 0.459238 |
| CBIT outreach | 0.565366 |
| real treatment option | 0.520989 |
| throat clearing tic | 0.530402 |
| Tourette Association | 0.472491 |
| behavioral therapy | 0.516103 |
| grunting sound | 0.471896 |
| CBIT treatment | 0.591049 |
| treatment option | 0.527179 |
| Dr. Doug Woods | 0.502114 |
| CBIT | 0.799535 |
| spinal cord | 0.464647 |
| systematic way | 0.461771 |
| people | 0.607339 |
| Dr. Leon Dure | 0.506464 |
| randomized controlled trial | 0.496159 |
| education professionals | 0.466852 |
| A. L. | 0.496946 |
| D. W. | 0.498226 |
| J. T. | 0.492089 |
|
CLICK HERE |
| 10754 |
Centers for Disease Control and Prevention |
Html |
en |
For Researchers - Pregnancy Risk Assessment Monitoring System - Reproductive Health |
PRAMS for Researchers |
| PRAMS Topic Reference | 0.637775 |
| following variables | 0.228012 |
| single pdf file | 0.287838 |
| PRAMS states | 0.563758 |
| PRAMS Research Dataset | 0.665197 |
| response rate threshold | 0.317534 |
| PRAMS Set-up | 0.528474 |
| SAS Complex Survey | 0.266654 |
| SPSS Complex Samples | 0.273361 |
| standardized optional questions | 0.251215 |
| data sets | 0.4129 |
| application form | 0.289667 |
| PRAMS data | 0.801178 |
| additional Questionnaire Variables | 0.351027 |
| individual state approval | 0.2745 |
|
| PRAMS complex survey | 0.659059 |
| PRAMS questionnaire | 0.655861 |
| coordinator contact information | 0.257643 |
| PRAMS Analytic Research | 0.906668 |
| birth certificate variables | 0.51158 |
| PRAMS | 0.921113 |
| data sharing agreement | 0.533202 |
| Standard Question Lists | 0.259535 |
| additional Birth Certificate | 0.256067 |
| Complete proposals | 0.207574 |
| review date | 0.288996 |
| PRAMS coordinators | 0.518497 |
| Analytic Research File | 0.514265 |
| Proposal Guidelines | 0.327384 |
| Proposal reviews | 0.20841 |
|
CLICK HERE |
| 12495 |
Centers for Disease Control and Prevention |
Video |
en |
February 2014 ACIP Meeting -- Pneumococcal Conjugate Vaccine (PCV) -- Part 1 |
Introduction, Update on Effectiveness and Impact of PCV13 use among U.S. Children, and GRADE for 3-dose PCV13 schedules.
Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html
This video can also be viewed at
pneumococcal conjugate vaccine, PCV13, PC13 use, PC13 schedules, GRADE |
| PCV | 0.482323 |
| Pneumococcal Conjugate Vaccine | 0.984626 |
|
|
CLICK HERE |
| 12710 |
Centers for Disease Control and Prevention |
Video |
en |
A Key Piece of the Puzzle: Vaccinations Video |
Parents work hard to keep their babies healthy and safe. But, even healthy babies need vaccines to protect them from serious diseases. By vaccinating them according to CDC's recommended schedule, parents can protect their babies from 14 serious diseases before they turn two years old.
Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html
This video can also be viewed at:
http://www.cdc.gov/cdctv/KeyPuzzle60/ |
| Puzzle | 0.730359 |
| Key Piece | 0.954952 |
|
|
CLICK HERE |
| 13735 |
Centers for Disease Control and Prevention |
Html |
en |
National Latino AIDS Awareness Day - October 15,2015 |
National Latino AIDS Awareness Day is observed each year on October 15 to focus on the continuing and disproportionate impact of human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS) on the Hispanic or Latino population in the United States. Hispanics or Latinos represent approximately 17% of the U.S. |
| endorsement | 0.443993 |
| engagement | 0.414932 |
| Human Services | 0.561834 |
| U.S. Department | 0.560629 |
| MMWR HTML versions | 0.551133 |
| Latino AIDS Awareness | 0.913772 |
| electronic PDF version | 0.5459 |
| viral suppression | 0.490504 |
| Hispanic | 0.415063 |
| Additional information | 0.570166 |
| Contact GPO | 0.498648 |
| diagnosis | 0.415013 |
| opportunity | 0.414776 |
| commercial sources | 0.486004 |
| HIV medical care | 0.628909 |
| current prices | 0.481408 |
| persons | 0.415153 |
| original paper copy | 0.542292 |
| human immunodeficiency virus | 0.597096 |
| HIV prevention activities | 0.625618 |
| Latinos | 0.607889 |
| disproportionate impact | 0.511835 |
| treatment | 0.414587 |
| United States | 0.587327 |
|
| original MMWR paper | 0.547837 |
| U.S. Government Printing | 0.547501 |
| antiretroviral therapy | 0.497574 |
| 100,000 | 0.416149 |
| Superintendent | 0.415529 |
| linkage | 0.417049 |
| new diagnoses | 0.500596 |
| MMWR readers | 0.487098 |
| character translation | 0.48126 |
| immunodeficiency syndrome | 0.516113 |
| CDC resources | 0.510788 |
| National Latino AIDS | 0.913897 |
| format errors | 0.481682 |
| Latino population | 0.523077 |
| Health | 0.428083 |
| typeset documents | 0.485182 |
| trade names | 0.486069 |
| official text | 0.480148 |
| U.S. population | 0.49963 |
| non-CDC sites | 0.484057 |
| HIV testing | 0.550297 |
| electronic conversions | 0.479493 |
| HIV infection | 0.727991 |
| Hispanics | 0.608713 |
|
CLICK HERE |
| 14322 |
Centers for Disease Control and Prevention |
Image |
null |
Radiation Emergencies and Pregnancy| Infographic |
null |
|
|
CLICK HERE |